http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0514009-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7013fad971f277ee33268470cdaf7dff |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 |
| filingDate | 1992-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1995-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de1f571a3cca99e73a40d659589b21b7 |
| publicationDate | 1995-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0514009-B1 |
| titleOfInvention | Corneal treatment agents |
| abstract | Pharmaceutical compositions comprising aliphatic alcohols are disclosed for use in therapy, for example eye therapy and in particular for the treatment of discomfort and visual artifacts following laser surgical procedures on the cornea of the eye. Such compositions reduce the inflammation associated with photorefractive keratectomy and promote the regrowth of epithelial tissue over the reprofiled corneal surface. The compositions may comprise aliphatic alcohols having a chain length ranging from about C-20 to about C-26, and may include docosanol, tetracosanol or hexacosanol, or mixtures thereof. |
| priorityDate | 1991-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.